R. Stephanie Huang

Ineffectiveness and/or severe toxicity are commonly associated with cancer therapy. Stephanie Huang is an international leader in the field of pharmacogenomics of anticancer therapy. She develops novel models to translate complex cancer molecular profiles to therapeutic decisions. Her work enables the identification and repurposing of efficacious drugs to treat cancers and tailor therapy to the right patients. The net result is faster, less costly development of more effective, less toxic anticancer medications.